NO20034874L - Aerosolformuleringer for pulmonaradministrasjon av medikamenter for frembringelse av en systemisk effekt - Google Patents

Aerosolformuleringer for pulmonaradministrasjon av medikamenter for frembringelse av en systemisk effekt

Info

Publication number: NO20034874L
Authority: NO; Norway
Prior art keywords: drugs; produce; pulmonary administration; aerosol formulations; systemic effect
Prior art date: 2002-03-01

Application number

NO20034874A

Other languages

English (en)

Other versions

NO20034874D0 (no

Inventor

Rebecca Jaine Davies

David Ganderton

David Andrew Lewis

Brian John Meakin

Gaetano Brambilla

Alessandra Ferraris

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-01

Filing date

2003-10-31

Publication date

2003-12-23

2003-10-31 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2003-10-31 Publication of NO20034874D0 publication Critical patent/NO20034874D0/no

2003-12-23 Publication of NO20034874L publication Critical patent/NO20034874L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Dispersion Chemistry (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20034874A 2002-03-01 2003-10-31 Aerosolformuleringer for pulmonaradministrasjon av medikamenter for frembringelse av en systemisk effekt NO20034874L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02004786A EP1340492A1 (en)	2002-03-01	2002-03-01	Aerosol formulations for pulmonary administration of medicaments having systemic effects
PCT/EP2003/001962 WO2003074023A1 (en)	2002-03-01	2003-02-26	Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect

Publications (2)

Publication Number	Publication Date
NO20034874D0 NO20034874D0 (no)	2003-10-31
NO20034874L true NO20034874L (no)	2003-12-23

Family

ID=27675679

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034874A NO20034874L (no)	2002-03-01	2003-10-31	Aerosolformuleringer for pulmonaradministrasjon av medikamenter for frembringelse av en systemisk effekt

Country Status (27)

Country	Link
US (1)	US20050129621A1 (no)
EP (2)	EP1340492A1 (no)
JP (1)	JP2005519094A (no)
KR (1)	KR20040091050A (no)
CN (2)	CN1638731A (no)
AR (2)	AR038643A1 (no)
AT (1)	ATE488224T1 (no)
AU (1)	AU2003215597B2 (no)
BR (1)	BR0303348A (no)
CA (1)	CA2477879C (no)
DE (1)	DE60334973D1 (no)
EA (1)	EA008571B1 (no)
ES (1)	ES2358293T3 (no)
GE (1)	GEP20063985B (no)
HR (1)	HRP20040751A2 (no)
IL (1)	IL163842A0 (no)
MA (1)	MA27107A1 (no)
MX (1)	MXPA04008370A (no)
NO (1)	NO20034874L (no)
NZ (1)	NZ535019A (no)
PE (1)	PE20030949A1 (no)
PL (1)	PL372261A1 (no)
TN (1)	TNSN04148A1 (no)
TW (1)	TW200304833A (no)
UA (2)	UA81238C2 (no)
WO (1)	WO2003074023A1 (no)
ZA (3)	ZA200406917B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010031244A1 (en) *	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
IT1303788B1 (it) *	1998-11-25	2001-02-23	Chiesi Farma Spa	Formulazioni di aerosol medicinali.
DZ2947A1 (fr) *	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
US6315985B1 (en) *	1999-06-18	2001-11-13	3M Innovative Properties Company	C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1317720B1 (it) *	2000-01-07	2003-07-15	Chiesi Farma Spa	Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1318514B1 (it) *	2000-05-12	2003-08-27	Chiesi Farma Spa	Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
US20060257324A1 (en) *	2000-05-22	2006-11-16	Chiesi Farmaceutici S.P.A.	Pharmaceutical solution formulations for pressurised metered dose inhalers
BR0015884A (pt) *	2000-05-22	2003-07-08	Chiesi Farma Spa	Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
ATE267591T1 (de) *	2001-07-02	2004-06-15	Chiesi Farma Spa	Optimierte tobramycin-formulierung zur aerosolbildung
KR100947409B1 (ko) *	2002-03-01	2010-03-12	키에시 파르마슈티시 엣스. 피. 에이.	포모테롤 초미세 조성물
EP1415647A1 (en) *	2002-10-23	2004-05-06	CHIESI FARMACEUTICI S.p.A.	"Long-acting beta-2 agonists ultrafine formulations"
EP1452179A1 (en) *	2003-02-27	2004-09-01	CHIESI FARMACEUTICI S.p.A.	Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
GB0311701D0 (en) *	2003-05-21	2003-06-25	Karib Kemi Pharm Liited	Improved metered dose inhaler product
SG146648A1 (en) *	2003-09-15	2008-10-30	Vectura Ltd	Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
EP1595531A1 (en)	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stable pharmaceutical solution formulations for pressurized metered dose inhalers
KR20070000476A (ko) *	2004-02-27	2007-01-02	키에시 파르마슈티시 엣스. 피. 에이.	압축화 계량된 도스흡입용 안정된 약제용액 제제
EP1809243B2 (de) *	2004-07-02	2022-06-08	Boehringer Ingelheim International GmbH	Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
WO2007034207A2 (en) *	2005-09-25	2007-03-29	Cipla Limited	Troventol formulation
US20070243262A1 (en) *	2005-12-21	2007-10-18	Hurley Kevin P	Stable S-nitrosothiol formulations
DE102006017320A1 (de) *	2006-04-11	2007-10-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
EP2011534A1 (en) *	2007-07-03	2009-01-07	CHIESI FARMACEUTICI S.p.A.	Metered dose inhaler actuator
PE20090907A1 (es) *	2007-07-21	2009-08-05	Boehringer Ingelheim Int	Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente
EP2211956A4 (en)	2007-10-10	2014-07-09	Parion Sciences Inc	DISPOSAL OF OSMOLYTES WITH A NOSE CANNULA
WO2010074753A1 (en) *	2008-12-23	2010-07-01	Map Pharmaceuticals, Inc.	Inhalation devices and related methods for administration of sedative hypnotic compounds
WO2012007130A1 (en) *	2010-07-12	2012-01-19	Xellia Pharmaceuticals Aps	Treatment of lung infections by administration of tobramycin by aerolisation
WO2012039855A1 (en)	2010-09-22	2012-03-29	The Board Of Regents Of The University Of Texas System	Ph-sensitive compositions for delivery of beta lapachone and methods of use
US8778383B2 (en)	2011-06-07	2014-07-15	Parion Sciences, Inc.	Methods of treatment
US8945605B2 (en) *	2011-06-07	2015-02-03	Parion Sciences, Inc.	Aerosol delivery systems, compositions and methods
US20130156823A1 (en) *	2011-12-20	2013-06-20	MAP Pharmacauticals, Inc.	Excipient-free Aerosol Formulation
GB201402513D0 (en)	2014-02-13	2014-04-02	Cardiff Scintigraphics Ltd	Pressurised metered dose inhalers and method of manufacture
US10610512B2 (en)	2014-06-26	2020-04-07	Island Breeze Systems Ca, Llc	MDI related products and methods of use
CA2986593A1 (en) *	2015-05-21	2016-11-24	Island Breeze Systems Ca, Llc	Propellant based metered dose inhaler and food applicators and applicators
US11129848B2 (en)	2017-08-08	2021-09-28	Perricone Hydrogen Water Company, Llc	Medication enhancement using hydrogen
GB201912686D0 (en) *	2019-09-04	2019-10-16	Reown Pharma Inc	Pharmaceutical composition
US11123365B2 (en)	2019-11-18	2021-09-21	Perricone Hydrogen Water Company, Llc	Compositions comprising palmitoylethanolamide and hydrogen water, and methods thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU726510B2 (en) *	1996-12-04	2000-11-09	Consort Medical Plc	Pharmaceutical compositions and devices for their administration
US20010031244A1 (en) *	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
GB2326334A (en) *	1997-06-13	1998-12-23	Chiesi Farma Spa	Pharmaceutical aerosol compositions
US6309623B1 (en) *	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
US6284282B1 (en) *	1998-04-29	2001-09-04	Genentech, Inc.	Method of spray freeze drying proteins for pharmaceutical administration
IT1303788B1 (it) *	1998-11-25	2001-02-23	Chiesi Farma Spa	Formulazioni di aerosol medicinali.
DZ2947A1 (fr) *	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
WO2001019342A2 (en) *	1999-09-11	2001-03-22	Glaxo Group Limited	Pharmaceutical formulation of fluticasone propionate
IT1317720B1 (it) *	2000-01-07	2003-07-15	Chiesi Farma Spa	Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1317846B1 (it) *	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US20030191180A1 (en) *	2000-03-09	2003-10-09	Calvin Ross	Pharmaceutical compositions
BR0005797A (pt) *	2000-03-20	2001-10-16	Abbott Lab	Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
IT1318514B1 (it) *	2000-05-12	2003-08-27	Chiesi Farma Spa	Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
BR0015884A (pt) *	2000-05-22	2003-07-08	Chiesi Farma Spa	Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
KR100947409B1 (ko) *	2002-03-01	2010-03-12	키에시 파르마슈티시 엣스. 피. 에이.	포모테롤 초미세 조성물
EP1595531A1 (en) *	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stable pharmaceutical solution formulations for pressurized metered dose inhalers

2002
- 2002-03-01 EP EP02004786A patent/EP1340492A1/en not_active Withdrawn
2003
- 2003-02-26 NZ NZ535019A patent/NZ535019A/en unknown
- 2003-02-26 GE GEAP8390A patent/GEP20063985B/en unknown
- 2003-02-26 CA CA2477879A patent/CA2477879C/en not_active Expired - Fee Related
- 2003-02-26 ES ES03743339T patent/ES2358293T3/es not_active Expired - Lifetime
- 2003-02-26 AT AT03743339T patent/ATE488224T1/de active
- 2003-02-26 HR HRP20040751 patent/HRP20040751A2/hr not_active Application Discontinuation
- 2003-02-26 WO PCT/EP2003/001962 patent/WO2003074023A1/en not_active Ceased
- 2003-02-26 AU AU2003215597A patent/AU2003215597B2/en not_active Ceased
- 2003-02-26 CN CNA038049775A patent/CN1638731A/zh active Pending
- 2003-02-26 BR BR0303348-1A patent/BR0303348A/pt not_active IP Right Cessation
- 2003-02-26 UA UA20040806744A patent/UA81238C2/uk unknown
- 2003-02-26 IL IL16384203A patent/IL163842A0/xx unknown
- 2003-02-26 EA EA200401006A patent/EA008571B1/ru not_active IP Right Cessation
- 2003-02-26 US US10/505,679 patent/US20050129621A1/en not_active Abandoned
- 2003-02-26 JP JP2003572543A patent/JP2005519094A/ja active Pending
- 2003-02-26 EP EP03743339A patent/EP1480616B1/en not_active Expired - Lifetime
- 2003-02-26 PL PL03372261A patent/PL372261A1/xx not_active Application Discontinuation
- 2003-02-26 MX MXPA04008370A patent/MXPA04008370A/es unknown
- 2003-02-26 DE DE60334973T patent/DE60334973D1/de not_active Expired - Lifetime
- 2003-02-26 KR KR10-2004-7012649A patent/KR20040091050A/ko not_active Ceased
- 2003-02-27 UA UA20040806968A patent/UA80695C2/uk unknown
- 2003-02-27 CN CNA2009100074339A patent/CN101502500A/zh active Pending
- 2003-02-27 TW TW092104190A patent/TW200304833A/zh unknown
- 2003-02-28 PE PE2003000200A patent/PE20030949A1/es not_active Application Discontinuation
- 2003-02-28 AR ARP030100686A patent/AR038643A1/es unknown
- 2003-10-31 NO NO20034874A patent/NO20034874L/no not_active Application Discontinuation
2004
- 2004-08-06 TN TNP2004000148A patent/TNSN04148A1/en unknown
- 2004-08-09 MA MA27816A patent/MA27107A1/fr unknown
- 2004-08-31 ZA ZA200406917A patent/ZA200406917B/xx unknown
- 2004-08-31 ZA ZA200406918A patent/ZA200406918B/xx unknown
- 2004-08-31 ZA ZA200406919A patent/ZA200406919B/en unknown
2015
- 2015-08-19 AR ARP150102671A patent/AR101593A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200406918B (en)	2006-06-28
DE60334973D1 (de)	2010-12-30
NZ535019A (en)	2006-09-29
PL372261A1 (en)	2005-07-11
CN1638731A (zh)	2005-07-13
MA27107A1 (fr)	2004-12-20
AU2003215597B2 (en)	2008-07-31
CA2477879C (en)	2011-05-03
JP2005519094A (ja)	2005-06-30
EP1480616B1 (en)	2010-11-17
ZA200406919B (en)	2006-06-28
NO20034874D0 (no)	2003-10-31
MXPA04008370A (es)	2004-11-26
ZA200406917B (en)	2006-06-28
AR101593A2 (es)	2016-12-28
EA008571B1 (ru)	2007-06-29
IL163842A0 (en)	2005-12-18
UA80695C2 (en)	2007-10-25
AR038643A1 (es)	2005-01-19
HRP20040751A2 (en)	2004-12-31
EA200401006A1 (ru)	2005-04-28
EP1480616A1 (en)	2004-12-01
WO2003074023A1 (en)	2003-09-12
ES2358293T3 (es)	2011-05-09
TW200304833A (en)	2003-10-16
AU2003215597A1 (en)	2003-09-16
EP1340492A1 (en)	2003-09-03
US20050129621A1 (en)	2005-06-16
ATE488224T1 (de)	2010-12-15
GEP20063985B (en)	2006-12-11
TNSN04148A1 (en)	2007-03-12
PE20030949A1 (es)	2004-01-02
BR0303348A (pt)	2004-07-13
CN101502500A (zh)	2009-08-12
CA2477879A1 (en)	2003-09-12
UA81238C2 (en)	2007-12-25
KR20040091050A (ko)	2004-10-27

Publication	Publication Date	Title
NO20034874D0 (no)	2003-10-31	Aerosolformuleringer for pulmonaradministrasjon av medikamenter for frembringelse av en systemisk effekt
NO20033343D0 (no)	2003-07-24	Farmasöytiske doseringsformer av epothiloner for oral administrasjon
NO20043866L (no)	2004-09-15	Farmasoytisk formulering av IRESSA omfattende et vannopploselig cellulosederivat
FI7617U1 (fi)	2007-09-28	Amorfisen aktiivisen ainesosan stabiloitu farmaseuttinen valmiste
IS2639B (is)	2010-06-15	Staðbundin lyfjablanda
NO20042842L (no)	2004-07-05	Farmasoytiske formuleringer av platina-derivat
FR2847253B1 (fr)	2007-05-18	Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
EP1435894A4 (en)	2005-07-06	CYTOPROTECTIVE COMPOUNDS, PHARMACEUTICAL AND COSMETIC FORMULATIONS AND METHOD
EE200200439A (et)	2003-12-15	Tsentraalsete kannabinoidiretseptorite antagonisti kasutamine ravimtoodete valmistamiseks, aitamaksloobuda tubakatarbimisest
AU2001231000A1 (en)	2001-07-31	Dry powder formulations of antihistamine for nasal administration
EP1646276A4 (en)	2013-05-15	SPRAY FOR THE PRODUCTION OF A MEDICAMENT IN AEROSOL FORM
NO20025592D0 (no)	2002-11-21	Kontinuerlig produksjon av farmasöytisk granulering
DK1399127T3 (da)	2005-06-13	Olopatadinformuleringer til topisk administration
PT1501534E (pt)	2006-09-29	Formulacoes farmaceuticas
HRP20040545A2 (en)	2005-08-31	Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
AU2002211863A1 (en)	2002-04-15	Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
CY2018005I2 (el)	2018-06-27	Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
NO20035438L (no)	2004-02-05	Farmasoytisk formulering for effektiv administrering av apomorfin, 6aR-(-)-N-propyl-norapomorfin og deres derivater og prodrugs derav
NO20014738L (no)	2001-10-23	Tolperisonholdig farmasöytisk preparat for oral administrering
NO20043832L (no)	2004-09-13	Oral fast losningsformulering av en darlig vannloselig aktiv substans
NO20025394D0 (no)	2002-11-11	Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer
DK1225902T3 (da)	2005-05-02	Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
FI20000780L (fi)	2001-10-04	Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO20084860L (no)	2009-01-08	Stabile farmasøytiske preparater av 2-aza-bisyklo-[3,3,0]-oktan-3-karboksylsyrederivater
EP1725256A4 (en)	2008-12-31	VACCINE FORMULATION FOR ADMINISTRATION TO THE LUNGSSCHLEIMHAUT

Legal Events

Date	Code	Title	Description
2009-10-05	FC2A	Withdrawal, rejection or dismissal of laid open patent application